Legend Biotech Corp ADR (LEGN): Next-Year EPS Estimate 4122.43%
As of 2026-08-04, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 4122.43%. Featured in 3 EPS revision reports, most recently on 2026-04-23.
On 2026-07-27, analyst consensus for LEGN's next-year EPS growth shifted from 4362.34% to 4122.43% — a negative change of 239.91 percentage points. The revised estimate has been sustained across 8 subsequent trading sessions. Current-year growth is projected at 102.29%.
What's Driving This
Analysts raised LEGN’s next-year EPS growth estimate to 4,122.43% on July 27, a 239.91 percentage-point upward revision that serves as the primary structural driver of the stock’s rise. No specific headline—such as an earnings beat, contract win, or guidance raise—clearly explains this upgrade. Recent news about Johnson & Johnson retaining stakes in rumored acquisition targets may add speculative interest, but it is not directly tied to the EPS change. The upward price trend has continued beyond the initial revision, suggesting sustained momentum.
Generated 2026-07-31 from news as of 2026-07-31
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 4122.43%
- EPS growth this year
- 102.29%
- EPS next quarter (est)
- $0.06
- Last price
- $19.13
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-04 | 4122.43% | 102.29% | $0.06 | $19.13 |
| 2026-08-03 | 4122.43% | 102.29% | $0.06 | $19.01 |
| 2026-08-02 | 4122.43% | 102.29% | $0.06 | $18.55 |
| 2026-07-31 | 4122.43% | 102.29% | $0.06 | $18.55 |
| 2026-07-30 | 4122.43% | 102.29% | $0.06 | $19.05 |
| 2026-07-29 | 4122.43% | 102.29% | $0.06 | $18.85 |
| 2026-07-28 | 4122.43% | 102.29% | $0.06 | $19.04 |
| 2026-07-27 | 4122.43% | 102.29% | $0.06 | $19.27 |
| 2026-07-26 | 4362.34% | 102.22% | $0.06 | $22.22 |
| 2026-07-24 | 4362.34% | 102.22% | $0.06 | $22.22 |
| 2026-07-23 | 5314.76% | 101.84% | $0.05 | $23.53 |
| 2026-07-22 | 5314.76% | 101.84% | $0.05 | $23.53 |
| 2026-07-21 | 5314.76% | 101.84% | $0.05 | $23.54 |
| 2026-07-20 | 5314.76% | 101.84% | $0.05 | $23.21 |
| 2026-07-19 | 5314.76% | 101.84% | $0.05 | $22.26 |
| 2026-07-17 | 5314.76% | 101.84% | $0.05 | $22.26 |
| 2026-07-16 | 5314.76% | 101.84% | $0.05 | $22.71 |
| 2026-07-15 | 5018.63% | 101.95% | $0.06 | $23.04 |
| 2026-07-14 | 4904.93% | 102.00% | $0.05 | $25.67 |
| 2026-07-13 | 4695.42% | 102.10% | $0.05 | $25.75 |
| 2026-07-12 | 3717.42% | 102.61% | $0.06 | $27.08 |
| 2026-07-09 | 3717.42% | 102.61% | $0.06 | $27.38 |
| 2026-07-08 | 3717.42% | 102.61% | $0.06 | $27.87 |
| 2026-07-07 | 3714.05% | 102.61% | $0.06 | $27.68 |
| 2026-07-06 | 4111.90% | 102.37% | $0.07 | $28.04 |
| 2026-07-05 | 3487.99% | 102.78% | $0.07 | $29.91 |
| 2026-07-02 | 3487.99% | 102.78% | $0.07 | $29.91 |
| 2026-07-01 | 2861.13% | 103.44% | $0.07 | $29.89 |
| 2026-06-30 | 2861.13% | 103.44% | $0.07 | $28.88 |
| 2026-06-29 | 2861.13% | 103.44% | $0.07 | $29.39 |
Reports Featuring LEGN
Recent News
Screen Performance
Aggregate stats across all 1911 tickers our top-EPS-revision screen has flagged over the past 125 days.
- Median return since detection
- +4.2%
- % of tickers in the green
- 58%
- Median return on winners
- +20.9%
- Large revisions captured
- 1244
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Legend Biotech Corp ADR's next-year EPS growth estimate?▾
As of 2026-08-04, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 4122.43%, based on analyst consensus.
When was the latest EPS estimate revision for LEGN?▾
The most recent revision occurred on 2026-07-27, when analysts adjusted the next-year EPS growth estimate from 4362.34% to 4122.43%.
What sector and industry does Legend Biotech Corp ADR belong to?▾
Legend Biotech Corp ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. LEGN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Legend Biotech Corp ADR (LEGN) appears here because it was detected by our daily top-EPS-revision-performer screen.